Neuroleptic malignant syndrome following initiation of clozapine therapy.
Dalkilic
A
A
Grosch
W N
WN
D014150:Antipsychotic Agents / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000201:enzymology / Q000209:etiology*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*
D014150:Antipsychotic Agents; D003404:Creatinine; D003402:Creatine Kinase; D003024:Clozapine